Innate Immunity in AD Seminar
- medsoc78
- Oct 7
- 1 min read
Michael Heneka has been the director of the Luxembourg Centre for Systems Biomedicine at the University of Luxembourg since 2021. He is a board-certified neurologist and clinician-scientist with over 25 years of experience in studying neurodegenerative diseases at experimental, preclinical and clinical levels. At the clinical level, he established a neurodegenerative outpatient unit at both the University of Münster and the University of Bonn. From 2016 to 2021, he led the department of Neurodegenerative Disease and Geriatric Psychiatry in Bonn. He is further adjunct professor at the University of Massachusetts Chan Medical School and at the University of Bonn. His work has H-index ~118 and over 63,000 citations.
The Michael Heneka laboratory studies the interaction between the innate and adaptive immunity and the central nervous system. Inflammatory changes represent a common hallmark in neurodegenerative disorders including amyotrophic lateral sclerosis (ALS), fronto-temporal dementia (FTD) and Alzheimer’s disease (AD).
Please register at Eventbrite to easily notify of any changes.
Time: Oct 2, 2025 01:00 PM London
Meeting ID: 873 9133 1339
Passcode: 055965
Comments